Value of CYP2C19 *2 and *17 genotyping in clinical practice. Promising but not ready yet

Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):205-7. doi: 10.1016/j.recesp.2011.09.024. Epub 2012 Jan 28.
[Article in English, Spanish]
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acute Coronary Syndrome / genetics*
  • Aryl Hydrocarbon Hydroxylases / genetics*
  • Clopidogrel
  • Cytochrome P-450 CYP2C19
  • Female
  • Humans
  • Male
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use

Substances

  • Platelet Aggregation Inhibitors
  • Clopidogrel
  • Aryl Hydrocarbon Hydroxylases
  • CYP2C19 protein, human
  • Cytochrome P-450 CYP2C19
  • Ticlopidine